Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer

IF 4.7 2区医学 Q1 ONCOLOGY

Current Oncology Reports Pub Date : 2024-04-19 DOI:10.1007/s11912-024-01530-9

Mary Kathryn Abel, Ange Wang, Joseph M. Letourneau, Michelle E. Melisko, Marcelle I. Cedars, Mitchell P. Rosen

{"title":"Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer","authors":"Mary Kathryn Abel, Ange Wang, Joseph M. Letourneau, Michelle E. Melisko, Marcelle I. Cedars, Mitchell P. Rosen","doi":"10.1007/s11912-024-01530-9","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>In this Perspective we share the personal story of a 33-year-old patient diagnosed with metastatic breast cancer and her journey through fertility preservation, surrogacy, and eventually motherhood, highlighting misconceptions about fertility preservation in this population.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>There are nearly 1 million women under the age of 50 diagnosed and living with cancer in the USA. These patients are met with life-altering decisions, including those that may limit their reproductive ability. While there have been tremendous advances and advocacy in the field of oncofertility, there has been limited focus on patients with advanced stage or metastatic cancer.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>We describe five key misconceptions surrounding fertility preservation in patients with advanced stage cancer, offering a review of the literature and our approach to challenging topics like desiring fertility preservation in the face of Stage 4 disease, the safety and timing of ovarian stimulation during cancer treatment, and passing away following fertility preservation. We review the importance of assessing perceptions of fertility preservation in patients with metastatic cancer and highlight the lack of research in this area as a call to action.</p>","PeriodicalId":10861,"journal":{"name":"Current Oncology Reports","volume":"51 1","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Oncology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11912-024-01530-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of Review

In this Perspective we share the personal story of a 33-year-old patient diagnosed with metastatic breast cancer and her journey through fertility preservation, surrogacy, and eventually motherhood, highlighting misconceptions about fertility preservation in this population.

Recent Findings

There are nearly 1 million women under the age of 50 diagnosed and living with cancer in the USA. These patients are met with life-altering decisions, including those that may limit their reproductive ability. While there have been tremendous advances and advocacy in the field of oncofertility, there has been limited focus on patients with advanced stage or metastatic cancer.

Summary

We describe five key misconceptions surrounding fertility preservation in patients with advanced stage cancer, offering a review of the literature and our approach to challenging topics like desiring fertility preservation in the face of Stage 4 disease, the safety and timing of ovarian stimulation during cancer treatment, and passing away following fertility preservation. We review the importance of assessing perceptions of fertility preservation in patients with metastatic cancer and highlight the lack of research in this area as a call to action.

Abstract Image

查看原文本刊更多论文

改变对转移性癌症或晚期癌症妇女生育能力保护的看法

综述目的在本视角中，我们分享了一位被诊断为转移性乳腺癌的 33 岁患者的亲身经历，以及她从保留生育力、代孕到最终成为母亲的历程，并强调了对这一人群保留生育力的误解。这些患者面临着改变生活的决定，包括可能限制其生育能力的决定。摘要我们描述了围绕晚期癌症患者保留生育力的五个主要误解，对文献进行了综述，并介绍了我们在面对第四期疾病时希望保留生育力、癌症治疗期间卵巢刺激的安全性和时机以及保留生育力后去世等具有挑战性的话题时所采取的方法。我们回顾了评估转移性癌症患者对保留生育力的看法的重要性，并强调了这一领域研究的缺乏，呼吁人们采取行动。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Oncology Reports ONCOLOGY-

CiteScore

8.50

自引率

0.00%

发文量

187

审稿时长

6-12 weeks

期刊介绍： This journal aims to review the most important, recently published clinical findings in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by cancer. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as cancer prevention, leukemia, melanoma, neuro-oncology, and palliative medicine. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.